2月19日 - ** 制药商Ionis PharmaceuticalsIONS.O股价盘前上涨4.5%至33.40美元
** IONS在 (link)，第四季度销售额为2.27亿美元，高于分析师预计的1.376亿美元 - LSEG
** 公司报告第四季度亏损66美分/股，分析师预计亏损1.12美元/股 - LSEG
** 公司预计2025年营业收入将超过6亿美元；分析师平均预计2025年营业收入为6.76亿美元 - LSEG
** 截至2024年12月31日，IONS拥有现金、现金等价物和短期投资23亿美元。
** 公司预测 2025 年的现金、现金等价物和短期投资约为 17 亿美元
** 2024 年 IONS 下跌约 34
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.